JOHNSON & JOHNSON — Director's Dealing 2021

Jul 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVRx, Inc. (CVRX)
CIK: 0001235912
Period of Report: 2021-07-02

Reporting Person: JOHNSON & JOHNSON (10% Owner)
Reporting Person: Johnson & Johnson Innovation - JJDC, Inc. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-02	Common Stock	C	3495575	—	Acquired	3495575	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-02	Series D-2 Preferred Stock	$	C	4032259	Disposed		Common Stock (101958)	Indirect
2021-07-02	Series E-2 Preferred Stock	$	C	6451188	Disposed		Common Stock (163123)	Indirect
2021-07-02	Series F-2 Preferred Stock	$	C	7587828	Disposed		Common Stock (191864)	Indirect
2021-07-02	Series G Preferred Stock	$	C	48068690	Disposed		Common Stock (3038630)	Indirect

Footnotes

F1: Each share of preferred stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date. Shares of Series D-2 Preferred Stock, Series E-2 Preferred Stock and Series F-2 Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.025857287 and shares of Series G Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.0632143218 (in each case, subject to the payment of cash in lieu of any fractional shares). The conversion rates reported reflect the conversion ratios under the Issuer's certificate of incorporation, adjusted to give effect to the previously effected 1-for-39.548 reverse stock split of the Common Stock.

F2: These securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person.